What is the current Coccidiosis Vaccines market size?

The Coccidiosis Vaccines market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Coccidiosis Vaccines market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Coccidiosis Vaccines market?

Key drivers include rising awareness of animal health and increasing adoption of vaccination programs.

What are the major challenges facing the Coccidiosis Vaccines market?

Challenges include high development costs and stringent regulatory requirements.

Which regions are leading the Coccidiosis Vaccines market?

North America and Europe are leading the market, due to strong animal health infrastructure.

Who are the top companies in the Coccidiosis Vaccines market?

Top companies include Zoetis, Merck, and Boehringer Ingelheim, which offer a range of vaccine products.

What future opportunities exist in the Coccidiosis Vaccines market?

Future opportunities include emerging markets and innovative vaccine technologies, such as recombinant vaccines.

How is technology impacting the Coccidiosis Vaccines market?

Technology is improving vaccine development, manufacturing, and distribution, enhancing the future outlook.

What is the current regulatory landscape for the Coccidiosis Vaccines market?

The regulatory landscape is complex, with varying requirements across regions, affecting market growth and development.

Coccidiosis Vaccines - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Coccidiosis Vaccines by Application (Poultry, Rabbit, Others), by Types (Attenuated Vaccines, Non-attenuated Vaccines), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Coccidiosis Vaccines Market Size | CAGR 8.2 Forecast 2033

Coccidiosis Vaccines - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Coccidiosis Vaccines Market Overview

The Coccidiosis Vaccines market refers to the industry involved in the development, production, and distribution of vaccines for the prevention and treatment of coccidiosis, a parasitic disease affecting livestock. As the global animal health industry continues to evolve, the Coccidiosis Vaccines market size is anticipated to reach $340 million by 2026, with a growth outlook that is expected to drive the market forecast towards a significant expansion. The industry expansion will be shaped by various factors, including the increasing demand for animal protein, advancements in vaccine technology, and the rising awareness about animal health.

Loading chart…

The Coccidiosis Vaccines market is expected to grow at a CAGR of 7.5% during the forecast period, driven by macro drivers such as the increasing global population, rising demand for animal protein, and advancements in vaccine technology. Key forces shaping the industry include technology shifts towards more effective and efficient vaccine production, regulations related to animal health and welfare, and competitive intensity among market players. The largest region in the Coccidiosis Vaccines market is North America, while the fastest-growing region is Asia-Pacific. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, opportunities, and challenges to make strategic decisions and drive business growth.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MSD Animal Health; Boehringer Ingelheim; HIPRA; Bioproperties; Huvepharma; Nisseiken; Biopharm; Ceva Santé Animale; Vaxxinova; Foshan Standard Biotech; Qilu Qingda Bio-Pharmaceutical; Skystar Bio-pharm; Hlinte; Guangdong Winsun Bio-pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Coccidiosis Vaccines market is poised for significant growth, driven by increasing demand for effective and sustainable solutions to mitigate the impact of coccidiosis on animal health and productivity. The growth forecast for the Coccidiosis Vaccines market size is expected to be substantial, driven by advancements in vaccine technology and growing awareness about the importance of disease prevention in livestock.

Growth Drivers2 items

Advances in vaccine technology, such as the development of recombinant vaccines, are expected to drive growth in the Coccidiosis Vaccines market, offering improved efficacy and safety profiles.

Increasing demand for meat and poultry products, particularly in emerging economies, is fueling the need for effective coccidiosis control measures, thereby driving the growth of the Coccidiosis Vaccines market size.

Restraints2 items

High development costs and stringent regulatory requirements are major restraints for new entrants in the Coccidiosis Vaccines market, limiting the availability of innovative products.

The complexity of coccidiosis disease and the lack of standardization in vaccine development and manufacturing processes can hinder the growth forecast of the Coccidiosis Vaccines market.

Opportunities2 items

The increasing adoption of vaccination strategies in animal health, particularly in the poultry and livestock sectors, presents significant opportunities for growth in the Coccidiosis Vaccines market.

Collaborations between vaccine manufacturers, research institutions, and animal health companies can facilitate the development of novel Coccidiosis Vaccines, driving market expansion and improving the growth forecast.

Challenges2 items

Ensuring the cold chain integrity of vaccines, from manufacturing to administration, is a significant challenge in the Coccidiosis Vaccines market, particularly in regions with limited infrastructure.

The potential for antimicrobial resistance development due to the misuse or overuse of vaccines and antibiotics in animal health poses a challenge to the long-term sustainability of the Coccidiosis Vaccines market.

Market Segmentation

Loading chart…

The Coccidiosis Vaccines market can be segmented based on Application, which refers to the specific use of the vaccines in various industries. This segmentation is crucial in understanding the Coccidiosis Vaccines segmentation and its impact on the overall market size. The application segment includes subtypes such as poultry, livestock, and companion animals, each contributing to the market growth.

Another significant segmentation of the Coccidiosis Vaccines market is by Types, which includes subtypes such as live attenuated vaccines, killed vaccines, and subunit vaccines. This segmentation helps in understanding the different types of vaccines available in the market and their respective market shares. The types segment is essential in determining the market taxonomy and its effect on the overall market size.

Coccidiosis Vaccines Segmentation Breakdown7 items

Application

Poultry

Rabbit

Others

Types

Attenuated Vaccines

Non-attenuated Vaccines

Regional Insights

Loading chart…

The Coccidiosis Vaccines market growth is expected to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of vaccines, favorable policies, and significant investments in the animal health sector.

Key drivers for each region include: for North America, strong infrastructure, established ecosystem maturity, and high demographics; for Europe, stringent regulations, increased awareness, and growing demand; for Asia Pacific, rapidly expanding animal health market, government initiatives, and rising Coccidiosis Vaccines market growth; for Latin America, growing livestock production, improving _infrastructure_, and increasing adoption; and for Middle East & Africa, growing _demand_, expanding distribution networks, and rising _awareness_.

The regional forecast indicates a promising outlook for the Coccidiosis Vaccines market, with each region presenting unique opportunities and challenges. Understanding these regional dynamics is crucial for stakeholders to navigate the market effectively and capitalize on emerging trends.

Competitive Landscape

The Coccidiosis Vaccines market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Coccidiosis Vaccines competitive landscape is shaped by these factors, with companies competing to establish strong market positions. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies in the Coccidiosis Vaccines market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To address these challenges, companies must develop effective strategies to maintain their competitive edge.

MSD Animal Health: regional expansion

Boehringer Ingelheim: innovation pipeline

HIPRA: premium pricing

Bioproperties: local manufacturing

Huvepharma: OEM tie-ups

Nisseiken: vertical integration

Key Coccidiosis Vaccines Companies14 items

MSD Animal Health

Boehringer Ingelheim

HIPRA

Bioproperties

Huvepharma

Nisseiken

Biopharm

Ceva Santé Animale

Vaxxinova

Foshan Standard Biotech

Qilu Qingda Bio-Pharmaceutical

Skystar Bio-pharm

Hlinte

Guangdong Winsun Bio-pharmaceutical

Market Ecosystem

The Coccidiosis Vaccines ecosystem is a complex network of participants that create and capture value through the development, production, and distribution of vaccines. The ecosystem spans upstream, midstream, and downstream activities, involving technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the interaction of these participants, from the supply of raw materials to the delivery of vaccines to end users.

Raw material suppliers — providing vaccine components

OEMs/manufacturers — producing Coccidiosis Vaccines

Distributors/channel partners — delivering vaccines to end users

Service providers/after-sales — offering support and maintenance services

End users/buyers — purchasing and administering vaccines

Regulators/standards bodies — establishing vaccine safety and efficacy standards

Data/analytics providers — analyzing vaccine efficacy and market trends

In the Coccidiosis Vaccines ecosystem, control points are held by regulators and standards bodies, who influence adoption through safety and efficacy approvals. Dependency risks arise from input constraints, such as limited supply of raw materials, and standards, such as those set by regulatory bodies. Switching costs are high due to the specialized nature of vaccine production, and partnerships between manufacturers and distributors are critical for ensuring timely delivery to end users. A value chain analysis of the ecosystem reveals that these dynamics can vary by region, with different regulatory frameworks and market conditions influencing the flow of value.

Recent Industry Insights

The Coccidiosis Vaccines industry trends have witnessed significant developments over the last 12-18 months, with a notable emphasis on strategic partnerships and innovative product launches. Recent mergers and acquisitions have also played a crucial role in shaping the industry landscape. For instance, key players have collaborated to develop and distribute novel coccidiosis vaccines, enhancing their market presence and product offerings.

Furthermore, regulatory changes have influenced the Coccidiosis Vaccines market, with governments implementing stricter guidelines to ensure vaccine safety and efficacy. A shift in consumer trends has also been observed, with a growing preference for live vaccines over traditional inactivated vaccines. Additionally, funding rounds and expansions have been announced, aiming to support research and development of next-generation coccidiosis vaccines, ultimately driving growth in the Coccidiosis Vaccines industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide a comprehensive overview of the Coccidiosis Vaccines market. The market attractiveness is moderate, driven by increasing demand for effective disease prevention in livestock. The competitive intensity is high, with several key players competing for market share. The long-term outlook for the Coccidiosis Vaccines market outlook is positive, with growing awareness of animal health and well-being.

Innovation in vaccine development and formulation is expected to shape the market, with a focus on improved efficacy and safety. The demand-supply balance is currently stable, but may be impacted by factors such as regulatory changes and disease outbreaks. Key risk factors include the emergence of antibiotic-resistant strains and vaccine hesitancy among farmers.

11 items

1. Executive Summary

2. Coccidiosis Vaccines Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Coccidiosis Vaccines Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Coccidiosis Vaccines Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Poultry

6.1.2. Rabbit

6.1.3. Others

6.2. Global Coccidiosis Vaccines Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Attenuated Vaccines

6.2.2. Non-attenuated Vaccines

6.3. Global Coccidiosis Vaccines Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Coccidiosis Vaccines Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Coccidiosis Vaccines Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Coccidiosis Vaccines Market Competition by Key Manufacturers

8.1. Global Coccidiosis Vaccines Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Coccidiosis Vaccines: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. MSD Animal Health

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Boehringer Ingelheim

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. HIPRA

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bioproperties

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Huvepharma

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Nisseiken

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Biopharm

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Ceva Santé Animale

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Vaxxinova

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Foshan Standard Biotech

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Qilu Qingda Bio-Pharmaceutical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Skystar Bio-pharm

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Hlinte

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Guangdong Winsun Bio-pharmaceutical

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Coccidiosis Vaccines Market

Figure 4: Global Coccidiosis Vaccines Market: Drivers

Figure 5: Global Coccidiosis Vaccines Market: Challenges

Figure 6: Global Coccidiosis Vaccines Market: Trends

Figure 7: Global Coccidiosis Vaccines Market: Opportunity

Figure 8: Global Coccidiosis Vaccines Market: Restraint

Figure 9: Global Coccidiosis Vaccines Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Coccidiosis Vaccines Market Value (USD Million) By Region

Figure 15: Global Coccidiosis Vaccines Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Coccidiosis Vaccines Market Value (USD Million) By Region

Figure 23: Global Coccidiosis Vaccines Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Coccidiosis Vaccines Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Coccidiosis Vaccines Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Coccidiosis Vaccines Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Coccidiosis Vaccines Market Value (USD Million) By Region

Table 10: Global Coccidiosis Vaccines Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Coccidiosis Vaccines Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Coccidiosis Vaccines Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Coccidiosis Vaccines Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: MSD Animal Health Basic Information And Sales Area

Table 31: MSD Animal Health. Products Portfolio

Table 32: Boehringer Ingelheim Basic Information And Sales Area

Table 33: Boehringer Ingelheim. Products Portfolio

Table 34: HIPRA Basic Information And Sales Area

Table 35: HIPRA. Products Portfolio

Table 36: Bioproperties Basic Information And Sales Area

Table 37: Bioproperties. Products Portfolio

Table 38: Huvepharma Basic Information And Sales Area

Table 39: Huvepharma. Products Portfolio

Table 40: Nisseiken Basic Information And Sales Area

Table 41: Nisseiken. Products Portfolio

Table 42: Biopharm Basic Information And Sales Area

Table 43: Biopharm. Products Portfolio

Table 44: Ceva Santé Animale Basic Information And Sales Area

Table 45: Ceva Santé Animale. Products Portfolio

Table 46: Vaxxinova Basic Information And Sales Area

Table 47: Vaxxinova. Products Portfolio

Table 48: Foshan Standard Biotech Basic Information And Sales Area

Table 49: Foshan Standard Biotech. Products Portfolio

Table 50: Qilu Qingda Bio-Pharmaceutical Basic Information And Sales Area

Table 51: Qilu Qingda Bio-Pharmaceutical. Products Portfolio

Table 52: Skystar Bio-pharm Basic Information And Sales Area

Table 53: Skystar Bio-pharm. Products Portfolio

Table 54: Hlinte Basic Information And Sales Area

Table 55: Hlinte. Products Portfolio

Table 56: Guangdong Winsun Bio-pharmaceutical Basic Information And Sales Area

Table 57: Guangdong Winsun Bio-pharmaceutical. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Coccidiosis Vaccines Market Value (USD Million) By Region

Table 63: Global Coccidiosis Vaccines Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Coccidiosis Vaccines Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	MSD Animal Health; Boehringer Ingelheim; HIPRA; Bioproperties; Huvepharma; Nisseiken; Biopharm; Ceva Santé Animale; Vaxxinova; Foshan Standard Biotech; Qilu Qingda Bio-Pharmaceutical; Skystar Bio-pharm; Hlinte; Guangdong Winsun Bio-pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options